| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Acquired in-process research and development intangible assets | - | 0 | ||
| Total assets | 33,358 | 37,684 | ||
| Total stockholders equity | 25,378 | 28,867 | ||
| Total liabilities and stockholders equity | 33,358 | 37,684 | ||
Inmune Bio, Inc. (INMB)
Inmune Bio, Inc. (INMB)